Accessibility settings

This paper is in the following e-collection/theme issue:

Systematic Review Protocols (funded) (27)

Published on in Vol 6, No 2 (2017): February

Dr. Liew and Dr. Tan present SARAH study results on SIRveNIB trial for HCC

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials

Authors of this article:

Val Gebski1 Author Orcid Image ;   Emma Gibbs2 Author Orcid Image ;   Mihir Gandhi3 Author Orcid Image ;   Gilles Chatellier4 Author Orcid Image ;   Aurelia Dinut4 ;   Helena Pereira4 ;   Pierce KH Chow5 Author Orcid Image ;   Valérie Vilgrain6
Article Authors Cited by (9) Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.